PRESCIENT THERAPEUTICS LIMITED

ASX:PTXPharmaceuticals, Biotechnology & Life Sciences

1.05B shares on issueASX (delayed) · snapshot 11 Sept 20261.13B fully diluted+7.1% if every option and right converts$0.065price · delayed$68.3Mmarket cap · indicative

Today’s holders own 93.4% of what they think they own, once every option and right converts.

Moderate

Dilution risk

Runway 2–4 quarters; 4 cash raises in 24 months; share count grew 8% in 24 months

Absolute levels — not a ranking against other companies.

Cash runway2.3 quarters of funding

Share-count growth (24m)7.6%

Raise cadence (24m)4 cash raises

Options & rights overhang7.1% of shares

In-the-money supply1.3% of shares

Pending proposed issuesopen proposed issue (Appendix 3B)

PRESCIENT THERAPEUTICS LIMITED's ordinary share count was 1.05B as of August 2025, up 7.6% since August 2025. The company raised capital four times in the past 24 months for total disclosed proceeds of A$26.8M, most recently a A$7.0M Security Purchase Plan in August 2026. Options and rights on issue could convert into 75M new shares, equal to 7.1% of the current share count, of which 1% are in the money at the current share price; the nearest expiry falls in November 2026. At the June 2026 quarter the company reported A$6.7M in available cash, about 2.3 quarters of funding at its recent spending rate. One proposed securities issue (Appendix 3B) is pending, with an expected issue date in September 2026.

AI-generated summary of this page's cited filings · updated 10 Sept 2026

Get told when this changes

Set up alerts

Daily email alerts cover risk-level moves, new raises, pending proposed issues and option expiries for the companies you follow.

7.1%

Options & rights overhang

1.3%

In-the-money supply

Raises · last 12 months

2.3 qtrs

Cash cover · 2–4 quarters

Shares on issue — last 2 years

Ordinary shares on issue

Weekly counts from ASX records. Dots mark cash capital raises. Latest count 1.05B per ASX (delayed) (snapshot 11 Sept 2026).

Cash runway

2.3 qtrs

Two to four quarters of funding at the recent spend rate.

Funds operations to about Jan 2027 at the reported spend rate.

$6.7M cash after burn from the quarter ended 30 June 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds. Filed with the quarterly report: $9.0M cash at quarter end (item 4.6), 3.1 qtrs of funding on the company’s own estimate. Our figure above carries the filed quarter-end balance forward at the reported spend rate and adds announced raise proceeds.

Free account

13 quarters on record — Cash runway history

Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 30 June 2026.

Free account: 2 full company unlocks every month, no card.

Create free account See plans

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

Date	Form	Security	On issue, per this filing	Source
10 July 2026	3H · cancellation	PTX : ORDINARY FULLY PAID	1.05B	Appendix 3H
19 Dec 2025	3G · unquoted	PTX : ORDINARY FULLY PAID	1.05B	Appendix 3G
17 Nov 2025	3G · unquoted	PTX : ORDINARY FULLY PAID	1.05B	Appendix 3G
1 Sept 2025	3G · unquoted	PTX : ORDINARY FULLY PAID	1.05B	Appendix 3G
29 Aug 2025	2A · quoted issue	PTX : ORDINARY FULLY PAID	1.05B	Appendix 2A

Free account

16 filings on record — Full issuance history

Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).

Free account: 2 full company unlocks every month, no card.

Create free account See plans

Capital raises

4 cash raises in the last 24 months · 1 in the last 12 months

every 6.9 monthsaverage gap between raises

0.6 monthssince the most recent

1 July 2025 – 25 Aug 2026first to most recent in this window

$7.0M

Security Purchase Plan

25 Aug 2026 ACTIVE

Free account

4 raises on record — Full raise history

Issue price, shares issued, brokers and stated purpose for every raise on record.

Free account: 2 full company unlocks every month, no card.

Create free account See plans

Retail offer

An offer existing holders can take part in — the one structural advantage retail has in a raise. Dated recently and not yet recorded as complete.

Share purchase plan

dated 25 Aug 2026 · 18 days ago

Security Purchase Plan

Closing dates are not in the filings this site holds. Check the company's own announcement below before acting on this.

Free account

Offer terms

The offer price, and how it compares with the last traded price.

Free account: 2 full company unlocks every month, no card.

Create free account See plans

Forward supply

Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.

Free account

7 dated events on record — Forward supply calendar

Option expiries and proposed issues on one forward timeline, with the securities each could add.

Free account: 2 full company unlocks every month, no card.

Create free account See plans

Placement capacity

How much stock a company can place without asking holders. Listing Rule 7.1 allows 15% of ordinary securities in any 12 months, and every Appendix 3B states how much of it an issue uses.

No Appendix 3B in the last 12 months reports an issue under the 15% placement capacity (as at 2026-09-12).

Free account

Placement capacity — LR 7.1 / 7.1A

The filings behind the figure: every Appendix 3B in the window with what it says was issued under 7.1 and 7.1A, each row linked to its filing, and how many shares are left.

Free account: 2 full company unlocks every month, no card.

Create free account See plans

Pending proposed issues

1 proposed issue pending — Appendix 3B lodged, securities not yet issued. New shares from these issues are not in the counts above until quoted.

Paid plan

1 pending issue on record — Pending issue detail

Size, price, fees, broker and placement-capacity usage for each pending issue.

Unlocks on a paid plan

See plans

Options & convertible securities

7.1%

Options & rights overhang · of current shares

1.3%

In-the-money supply · at current price

74.9M

Potential new shares

Nov 2026

Nearest expiry

What a price move would switch on

At $0.065 today, 13.7M securities are in the money (1.3% of shares on issue). No more priced supply until 1.25× today’s price, which takes it to 37.7M (3.6% of shares).

Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.

Code	Security	Type	Exercise price	Expiry	On issue	Source
PTXAL	Options	Price-triggered	$0.41	4 Nov 2026	1.0M	Filing
PTXAP	Options	Price-triggered	$0.13	15 May 2027	1.4M	Filing
PTXAQ	Options	Price-triggered	$0.062	11 Dec 2028	1.4M	Filing
PTXAS	Options	Price-triggered	$0.060	31 Aug 2029	12.3M	Filing
PTXAT	Options	Price-triggered	$0.10	17 Nov 2029	34.7M	Filing
PTXAR	Options	Price-triggered	$0.081	20 Jan 2030	24.0M	Filing

“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column.

Free account

6 option lines on record — In-the-money value & price ladder

What each line is worth in the money today, the price ladder to the next tranche that converts, and the filing description behind every code.

Free account: 2 full company unlocks every month, no card.

Create free account See plans

Director dealings

Date	Director	Type	Shares	Options	Other	Value	Source
18 Nov 2025	Allen James Ebens Jr.	Other	—	2.6M	—	—	3Y notice
18 Nov 2025	Dr Gavin Shepherd	Other	17.5M	2.6M	—	—	3Y notice
18 Nov 2025	Ellen Gwen Feigal	Other	—	1.2M	—	—	3Y notice